2 AI Stocks Trading at a Discount Right Now That I Think Wall Street Has Wrong

The market is likely still anchoring on legacy business models, which creates a valuation lag when hardware becomes a distribution layer for recurring software revenue. For ARLO, the key second-order effect is margin normalization: once the install base is monetized, incremental revenue should carry much higher gross margin and lower working-capital drag than camera unit sales, which can re-rate the stock even without rapid top-line acceleration. The Samsung-style service partnership is especially important because it de-risks customer acquisition costs and suggests Arlo can scale through OEM channels rather than retail shelf space.

The bigger setup is that AI-enabled home security may be transitioning from a discretionary device category to a subscription utility, where the competitive battleground shifts from camera specs to software efficacy and ecosystem lock-in. That is a bad place for commoditized hardware competitors, but potentially good for platform-adjacent names that can embed services into existing consumer ecosystems. The main risk is that AI feature adoption stalls if consumers don’t perceive enough incremental value to pay monthly fees; that would cap ARPU expansion and keep ARLO stuck in a hardware multiple.

Evolv’s signal is stronger on customer economics than on headline growth: renewals after a regulatory overhang imply switching costs and operational embeddedness, not just hype. That matters because it changes the bear case from "sales quality risk" to "compliance discount," which can compress over months rather than destroy the model outright. The overlooked upside is that schools and venues are sticky, multi-year accounts with expansion potential, so each renewal cycle can lift ARR without proportionate sales spending.

The contrarian view is that the market may be overestimating permanent reputational damage from the regulatory event, especially if retention stays elevated on the next cohort. If that holds, both names could see multiple expansion before fundamentals fully re-accelerate, which is usually where the best returns come from. The risk is a fresh disclosure or another product-claim issue, which would force the market to re-price both trust and durability of the recurring revenue stream.